Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS
Date issued
2015Journal title
Asia-Pacific Journal of Clinical Oncology
Type of content
Publicación de congreso